세계의 뉴트라슈티컬 원료 시장 : 유형별, 용도별, 형태별, 기능별, 지역별 - 예측(-2029년)

Nutraceutical Ingredients Market by Type (Proteins, Amino Acids, and Probiotics), Application (Food, Beverages, Animal Nutrition, Dietary Supplements, Food For Special Medical Purposes (FSMP)), Form, Function, & Region - Global Forecast to 2029

US $ 4,950 ￦ 6,974,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,369,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,483,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,090,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 뉴트라슈티컬 원료 시장 규모는 크게 확대되고 있으며, 2024년 1,052억 달러에서 2029년 1,361억 달러로 5.3%의 유망한 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.

조사 범위
조사 대상 연도	2024-2029년
기준 연도	2023년
예측 기간	2024-2029년
검토 단위	금액(달러), 수량(킬로톤)
부문별	유형별, 용도별, 형태별, 기능별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 남미 및 기타 지역

만연한 영양 부족에 맞서기 위해 정부와 비정부기구(NGO)는 영양의 중요성을 강조하는 노력을 추진하고 있습니다. 예를 들어, 대규모 식품 강화 노력은 전 세계적으로 강화 식품의 보급을 크게 촉진했습니다. PATH(Program for Appropriate Technology in the Health Sector)와 같은 단체가 이러한 노력을 지원하고 있으며, PATH의 영양 강화 쌀(UltraRice) 이니셔티브는 부룬디, 인도, 브라질 및 기타 국가에서 확장 가능하고 효과적인 것으로 입증되어 규제 프레임워크와 영양 정책에 영향을 미치고 있습니다. 규제 프레임워크와 영양 정책에 영향을 미치고 있습니다. 이러한 이니셔티브는 영양 부족에 대응하는 것 외에도 식품 가공에 강화 성분 사용을 촉진하는 가이드라인을 수립하고 있습니다.

동물 영양학에서 사료 배합을 개선하기 위한 영양 보충제 원료의 인기가 높아지고 있습니다. 개선된 사료 첨가제는 동물의 건강, 성장 효율 및 제품 품질을 향상시키는 것을 목표로 하며, 전 세계적으로 증가하는 고품질 단백질 공급원에 대한 수요를 충족시키기 위해 개발되고 있습니다.

업계 내 파트너십은 시장 확대를 더욱 가속화할 것입니다. 예를 들어, Olam Agri Holdings Pte Ltd는 2030년까지 매일 수백만 명의 사람들에게 영양을 공급할 수 있도록 필수 미량 영양소를 대규모로 강화하기 위해 노력하고 있습니다. 이러한 노력은 업계의 지속가능성과 공중 보건에 대한 헌신을 촉진하는 동시에 전 세계적으로 강화 식품의 보급을 가속화할 것입니다. 이 시장은 지속적인 혁신, 규제 당국의 지원, 부문 간 협력을 통해 더욱 성장할 것으로 예상되며, 향후 세계 건강 증진 이니셔티브의 중요한 구성요소로서 뉴트라슈티컬 원료의 입지를 더욱 확고히 할 것으로 전망됩니다.

개개인의 특별한, 종종 질병이나 질환과 관련된 영양 요구 사항을 충족시키기 위해 특별히 제조된 식품을 특수 의료 목적 식품이라고 합니다. 당뇨병, 위장 장애, 대사 증후군과 같은 만성 질환 및 장애의 유병률 증가는 FSMP에서 뉴트라슈티컬 원료에 대한 수요가 지속적으로 증가하는 주요 요인이 되고 있습니다.

또한, 식품 알레르기 및 불내성의 확산으로 인해 알레르겐을 포함하지 않고 개인별 식이 제한에 맞춘 특수한 FSMP 제제의 필요성이 증가하고 있습니다. 따라서 안전할 뿐만 아니라 부작용 없이 영양 요구 사항을 충족시키는 효능을 가진 뉴트라슈티컬 원료를 추가해야 합니다. 의료용 영양 요법 개발을 통해 지원을 제공하는 규제 기관도 성분 배합의 혁신성을 인정하고 엄격한 건강 기준을 충족할 수 있도록 보장함으로써 이 부문을 지원하고 있습니다.

이 보고서는 세계 뉴트라슈티컬 원료 시장을 조사하여 유형별, 용도별, 형태별, 기능별, 지역별 동향, 시장 진입 기업 개요 등을 정리했습니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

• 소개
• 거시경제 지표
• 시장 역학

제6장 업계 동향

• 소개
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 가격 분석
• 밸류체인 분석
• 생태계
• 기술 분석
• 특허 분석
• 무역 분석
• 2024-2025년의 주요 회의와 이벤트
• 관세와 규제 상황
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 사례 연구 분석
• 투자와 자금 조달 시나리오
• GEN AI가 식품·음료 원료·첨가물에 미치는 영향

제7장 뉴트라슈티컬 원료 시장(유형별)

• 소개
• 단백질
• 아미노산
• 섬유와 특수 탄수화물
• 프로바이오틱스
• 식물 화학물질과 식물 추출물
• 프리바이오틱스
• 기능성 지방과 오일
• 비타민
• 미네랄
• 카로티노이드
• 기타

제8장 뉴트라슈티컬 원료 시장(용도별)

• 소개
• 식품
• 음료
• 동물 영양
• 식이보충제
• 특별 의료 목적 식품(FSMP)

제9장 뉴트라슈티컬 원료 시장(형태별)

• 소개
• 드라이
• 액체

제10장 뉴트라슈티컬 원료 시장(기능별)

• 소개
• 추가 보충제
• 의약품 보충제
• 스포츠 영양

제11장 뉴트라슈티컬 원료 시장(지역별)

• 소개
• 북미
• 유럽
• 아시아태평양
• 남미
• 기타 지역

제12장 경쟁 상황

• 개요
• 주요 진출 기업 전략/비책
• 매출 분석
• 시장 점유율 분석, 2023년
• 기업 평가 매트릭스 : 주요 진출 기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 기업 가치 평가와 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오와 동향

제13장 기업 개요

• 주요 진출 기업
  • CARGILL, INCORPORATED
  • ADM
  • INTERNATIONAL FLAVORS & FRAGRANCES INC.
  • BASF SE
  • ARLA FOODS AMBA
  • DSM-FIRMENICH
  • INGREDION
  • TATE & LYLE
  • AJINOMOTO CO., INC.
  • ASSOCIATED BRITISH FOODS PLC
  • CHR. HANSEN A/S
  • KYOWA KIRIN CO., LTD
  • GLANBIA PLC
  • FONTERRA CO-OPERATIVE GROUP LIMITED
  • KERRY GROUP PLC
• 기타 기업
  • DIVI'S LABORATORIES LIMITED
  • ROQUETTE FRERES
  • BENEO
  • KEMIN INDUSTRIES, INC.
  • GOLDEN GRAIN GROUP LIMITED
  • COSUCRA
  • PURIS
  • PROEON
  • CONAGEN, INC.
  • CHICKP

제14장 인접 시장과 관련 시장

제15장 부록

ksm

영문 목차

영문목차

The global nutraceutical ingredients market is on a trajectory of significant expansion, with an estimated value projected to reach USD 136.1 billion by 2029 from the 2024 valuation of USD 105.2 billion, displaying a promising Compound Annual Growth Rate (CAGR) of 5.3%.

Scope of the Report
Years Considered for the Study	2024-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD), Volume (Kilo Ton)
Segments	By Type, Application, Form, Function (Qualitative), And Region
Regions covered	North America, Europe, Asia Pacific, South America, and RoW

"Regulatory support and collaborative efforts across public and private sectors in eradicating undernourishment fuels the demand for nutraceutical ingredients market."

In order to combat widespread deficiencies, governments and non-governmental organisations (NGOs) are championing initiatives that highlight the significance of nutrition. Large-scale food fortification initiatives, for instance, have greatly increased the global adoption of fortified foods. These initiatives are supported by organisations such as PATH (Program for Appropriate Technology in Health). PATH's nutrient-fortifying rice kernels (UltraRice) initiative has proven scalable and effective in Burundi, India, Brazil, and other countries, impacting regulatory frameworks and nutritional policies. In addition to addressing nutritional deficiencies, these initiatives establish guidelines that promote the use of fortified ingredients in food processing.

Nutraceutical ingredients are becoming more and more popular in animal nutrition to improve feed formulations. Improved feed additives aim to enhance animal health, growth efficiency, and product quality, meeting the rising demand for high-quality protein sources globally.

Partnerships within the industry further accelerate market expansion. For instance, Olam Agri Holdings Pte Ltd has committed to fortifying staple foods with essential micronutrients at scale, so millions can be reached every day by 2030. Such initiatives promote the industry's dedication to sustainability and public health while accelerating the global uptake of fortified foods. The market is anticipated to grow further due to ongoing innovation, regulatory support, and cross-sector collaboration, solidifying nutraceutical ingredients' position as a key component of global health and wellness initiatives in the future.

"During the forecast period, the food for special medical purposes (FSMP) within the application segment is estimated to witness the highest CAGR in the nutraceutical ingredients market."

Food specially prepared to meet special, often disease- or medical-condition-related nutritional requirements of individuals is known as food for special medical purposes. The increasing prevalence of chronic diseases and disorders, such as diabetes, gastrointestinal problems, metabolic syndromes, and others, has been the primary driver for the ever-growing demand for nutraceutical ingredients in FSMP. For instance, the IDF Diabetes Atlas for 2021 estimates that 1 in 10 adults worldwide, or 537 million adults aged 20 to 79, have diabetes at present. By 2030, this number is expected to rise to 643 million, and by 2045, it is expected to reach 783 million. Among the specific health benefits that nutraceutical ingredients provide to these patient populations are symptom management, improved nutritional intake, and support for overall health.

Moreover, the prevalence of food allergies and intolerances has heightened the need for specialized FSMP formulations that are free from allergens and tailored to individual dietary restrictions. This necessitates the addition of nutraceutical ingredients that are not only safe but have the efficacy to meet nutritional requirements without adverse reactions. Regulatory agencies, which provide support through developments in medical nutrition therapies, are also boosting this segment by ensuring that stringent health standards are met while allowing innovations in ingredient formulation.

"High healthcare costs driving demand for preventive healthcare have positioned the US in North America region as the dominant market in the nutraceutical ingredients market."

The US holds a dominant position in the North American nutraceutical ingredients market. There is a great need for preventive healthcare solutions due to the high cost of healthcare in the country. According to a piece by the PETER G. Peterson Foundation, US healthcare spending hit USD 4.5 trillion in 2022, or USD 13,493 per person, much more than in other wealthy countries. Due to such high healthcare costs, Americans are encouraged to spend money on nutraceutical ingredients and other preventive measures in order to maintain their health and lower their long-term medical costs.

A 2023 CRN Consumer Survey on Dietary Supplements stated that 74 percent of US adults take dietary supplements, with 55 percent among them taking them regularly. This simply indicates the importance of dietary supplements in promoting health in the nation. The desire for proactive health management in the face of rising healthcare costs and rising consumer awareness are the driving forces behind this widespread use. This growth is also supported by strong research and development activities and a very encouraging regulatory environment that allows innovation in health products. Businesses in the US are better able to develop and commercialize innovative nutraceutical ingredients because of their sophisticated infrastructure and highly qualified workforce.

The break-up of the profile of primary participants in the nutraceutical ingredients market:

• By Company Type: Tier 1 - 51%, Tier 2 - 26%, and Tier 3 - 23%
• By Designation: CXO's - 24%, Managers - 43%, Executives- 33%
• By Region: North America - 25%, Europe - 20%, Asia Pacific - 45%, South America - 5%, and Rest of the World -5%

Prominent companies include Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Arla Foods amba (Denmark), Associated British Foods plc (UK), dsm-firmenich (Switzerland), Ingredion (US), Tate & Lyle (UK), Ajinomoto Co., Inc. (Japan), and Chr. Hansen A/S (Denmark).

Research Coverage:

This research report categorizes the nutraceutical ingredients market by applications (food, beverages, animal nutrition, dietary supplements, and foods for special medical purposes (FSMP)), type (proteins, amino acids, fibers & specialty carbohydrates, probiotics, phytochemicals & plant extracts, prebiotics, functional fats & oils, vitamins, minerals, carotenoids, and other types), form (dry and liquid), function (qualitative), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The report covers information about the key factors, such as drivers, restraints, opportunities, and challenges impacting the growth of the nutraceutical ingredients market. It also provides a detailed analysis of the major players in the market including their business overview, products offered; key strategies; partnerships, new product launches, expansions, and acquisitions. Competitive benchmarking of upcoming startups in the nutraceutical ingredients market is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall nutraceutical ingredients market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Growing demand for fortified food due to increased health consciousness

among consumers), restraints (Higher costs of fortified products dissuade large-scale usage and adoption), opportunities (Nutraceuticals as alternatives for pharmaceuticals), and challenges (Combating counterfeiting in the nutraceutical industry) influencing the growth of the nutraceutical ingredients market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the nutraceutical ingredients market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the nutraceutical ingredients market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nutraceutical ingredients market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Arla Foods amba (Denmark), Associated British Foods plc (UK), dsm-firmenich (Switzerland), Ingredion (US), Tate & Lyle (UK), Ajinomoto Co., Inc. (Japan), and Chr. Hansen A/S (Denmark) among others in the nutraceutical ingredients market strategies. The report also helps stakeholders understand the nutraceutical ingredients market and provides them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 UNIT CONSIDERED
  • 1.4.1 CURRENCY CONSIDERED
  • 1.4.2 VOLUME UNIT CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key insights from industry experts
    • 2.1.2.3 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
  • 2.2.3 SUPPLY-SIDE ANALYSIS
  • 2.2.4 DEMAND-SIDE ANALYSIS
• 2.3 DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 LIMITATIONS AND RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET
• 4.2 ASIA PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY KEY TYPE AND COUNTRY
• 4.3 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL SNAPSHOT
• 4.4 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE AND REGION
• 4.5 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION AND REGION
• 4.6 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM AND REGION

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 DEVELOPMENTS IN RETAIL INDUSTRY
  • 5.2.2 RISE IN NUMBER OF DUAL-INCOME HOUSEHOLDS
• 5.3 MARKET DYNAMICS
  • 5.3.1 DRIVERS
    • 5.3.1.1 Growing demand for fortified food due to increased health consciousness
    • 5.3.1.2 Rising incidences of chronic diseases
    • 5.3.1.3 Mandates on food fortification by government organizations
    • 5.3.1.4 Rise in awareness about feed quality
    • 5.3.1.5 Increase in personalized nutrition trends
    • 5.3.1.6 Rise in digital health platforms and wearable & implantable technologies
  • 5.3.2 RESTRAINTS
    • 5.3.2.1 Higher costs of fortified products dissuade large-scale usage and adoption
  • 5.3.3 OPPORTUNITIES
    • 5.3.3.1 Rising use of nutraceuticals as alternatives for pharmaceuticals
    • 5.3.3.2 Alternative sources to obtain functional fats & oils
  • 5.3.4 CHALLENGES
    • 5.3.4.1 Proliferation of counterfeit products
    • 5.3.4.2 Lack of consistency in regulations pertaining to various ingredients

6 INDUSTRY TRENDS

• 6.1 INTRODUCTION
• 6.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 6.3 PRICING ANALYSIS
  • 6.3.1 AVERAGE SELLING PRICE TREND, BY TYPE
  • 6.3.2 AVERAGE SELLING PRICE TREND, BY REGION
• 6.4 VALUE CHAIN ANALYSIS
  • 6.4.1 RAW MATERIAL SOURCING
  • 6.4.2 PRODUCTION & PROCESSING
  • 6.4.3 DISTRIBUTION
  • 6.4.4 END USERS
• 6.5 ECOSYSTEM
  • 6.5.1 DEMAND SIDE
    • 6.5.1.1 Ingredient manufacturers
    • 6.5.1.2 Technology providers
    • 6.5.1.3 Start-ups/emerging companies
  • 6.5.2 SUPPLY SIDE
    • 6.5.2.1 Regulatory bodies
    • 6.5.2.2 End users
• 6.6 TECHNOLOGY ANALYSIS
  • 6.6.1 KEY TECHNOLOGIES
    • 6.6.1.1 CRISPR and gene editing
  • 6.6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.6.2.1 Microencapsulated powder for probiotic action in food products
    • 6.6.2.2 Robotics leading to innovations in market
    • 6.6.2.3 Hologram sciences-platform for personalized nutrition and advice
  • 6.6.3 ADJACENT TECHNOLOGIES
    • 6.6.3.1 3D printing
• 6.7 PATENT ANALYSIS
• 6.8 TRADE ANALYSIS
  • 6.8.1 EXPORT SCENARIO OF NUTRACEUTICAL INGREDIENTS
    • 6.8.1.1 Import scenario of nutraceutical ingredients
• 6.9 KEY CONFERENCES AND EVENTS, 2024-2025
• 6.10 TARIFF AND REGULATORY LANDSCAPE
  • 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.10.2 REGULATORY FRAMEWORK
    • 6.10.2.1 Organizations/Regulations governing nutraceutical ingredients market
    • 6.10.2.2 North America
      • 6.10.2.2.1 Canada
      • 6.10.2.2.2 US
      • 6.10.2.2.3 Mexico
    • 6.10.2.3 European Union (EU)
    • 6.10.2.4 Asia Pacific
      • 6.10.2.4.1 Japan
      • 6.10.2.4.2 China
      • 6.10.2.4.3 India
      • 6.10.2.4.4 Australia & New Zealand
    • 6.10.2.5 Rest of the World (RoW)
      • 6.10.2.5.1 Brazil
    • 6.10.2.6 Probiotics
      • 6.10.2.6.1 Introduction
      • 6.10.2.6.2 National/International bodies for safety standards and regulations
      • 6.10.2.6.3 North America: Regulatory environment analysis
      • 6.10.2.6.4 Europe: Regulatory environment analysis
      • 6.10.2.6.5 Asia Pacific: Regulatory environment analysis
      • 6.10.2.6.6 South America: Regulatory environment analysis
    • 6.10.2.7 Prebiotics
      • 6.10.2.7.1 Introduction
      • 6.10.2.7.2 Asia Pacific
      • 6.10.2.7.3 North America
      • 6.10.2.7.4 European Union
• 6.11 PORTER'S FIVE FORCES ANALYSIS
  • 6.11.1 INTENSITY OF COMPETITIVE RIVALRY
  • 6.11.2 THREAT OF NEW ENTRANTS
  • 6.11.3 THREAT OF SUBSTITUTES
  • 6.11.4 BARGAINING POWER OF SUPPLIERS
  • 6.11.5 BARGAINING POWER OF BUYERS
• 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 6.12.2 BUYING CRITERIA
• 6.13 CASE STUDY ANALYSIS
  • 6.13.1 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY
  • 6.13.2 MAGNITUDE BIOSCIENCES AND AB BIOTEK HNH EVALUATED PROBIOTIC DEVELOPMENT WITH ETHICAL AND HIGH-THROUGHPUT TESTING
  • 6.13.3 ROQUETTE FRERES ACHIEVED COMPLETE AMINO ACID PROFILE WITH NUTRALYS PEA PROTEIN
• 6.14 INVESTMENT AND FUNDING SCENARIO
• 6.15 IMPACT OF GEN AI ON FOOD & BEVERAGE INGREDIENTS/ADDITIVES
  • 6.15.1 USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
  • 6.15.2 CASE STUDIES FOR GENERATIVE AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
    • 6.15.2.1 Flavor and ingredient innovation
    • 6.15.2.2 AI-enabled digital tools for consumer understanding and product development
    • 6.15.2.3 Personalized AI-developed nutrition platform
    • 6.15.2.4 AI and cloud technology to address challenges in F&B industry
  • 6.15.3 IMPACT OF GENERATIVE AI/AI ON NUTRACEUTICAL INGREDIENTS MARKET
  • 6.15.4 ADJACENT ECOSYSTEM WORKING ON GENERATIVE AI

7 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 PROTEINS
• 7.3 AMINO ACIDS
  • 7.3.1 BRANCHED CHAIN AMINO ACIDS
    • 7.3.1.1 Leucine
    • 7.3.1.2 Isoleucine
    • 7.3.1.3 Valine
  • 7.3.2 LYSINE
  • 7.3.3 METHIONINE
  • 7.3.4 THREONINE
  • 7.3.5 TRYPTOPHAN
  • 7.3.6 GLUTAMIC ACID
  • 7.3.7 PHENYLALANINE
  • 7.3.8 OTHER AMINO ACID TYPES
• 7.4 FIBERS & SPECIALTY CARBOHYDRATES
• 7.5 PROBIOTICS
• 7.6 PHYTOCHEMICALS & PLANT EXTRACTS
• 7.7 PREBIOTICS
• 7.8 FUNCTIONAL FATS & OILS
  • 7.8.1 POLYUNSATURATED FATTY ACIDS (PUFAS)
    • 7.8.1.1 Omega-3 fatty acids
    • 7.8.1.2 Omega-6 fatty acids
    • 7.8.1.3 Conjugated Linoleic Acid (CLA)
  • 7.8.2 OMEGA-9 FATTY ACIDS
  • 7.8.3 MEDIUM CHAIN TRIGLYCERIDES
  • 7.8.4 OTHER FUNCTIONAL FATS & OILS
• 7.9 VITAMINS
  • 7.9.1 VITAMIN A
  • 7.9.2 VITAMIN B
  • 7.9.3 VITAMIN C
  • 7.9.4 VITAMIN D
  • 7.9.5 VITAMIN E
  • 7.9.6 VITAMIN K
• 7.10 MINERALS
• 7.11 CAROTENOIDS
  • 7.11.1 LUTEIN
  • 7.11.2 ASTAXANTHIN
  • 7.11.3 ZEAXANTHIN
  • 7.11.4 B-CAROTENE
  • 7.11.5 LYCOPENE
  • 7.11.6 OTHER CAROTENOIDS
• 7.12 OTHER TYPES

8 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 FOOD
  • 8.2.1 TECHNOLOGICAL ADVANCEMENTS IN FOOD PROCESSING EQUIPMENT, HIGH HEALTHCARE COSTS, AND INCREASED INCIDENCES OF CHRONIC DISEASE TO DRIVE MARKET
  • 8.2.2 BAKERY & SNACKS
  • 8.2.3 CONFECTIONERY
  • 8.2.4 DAIRY
  • 8.2.5 MEAT & MEAT PRODUCTS
  • 8.2.6 BABY FOOD
  • 8.2.7 OTHER FOOD PRODUCTS
• 8.3 BEVERAGES
  • 8.3.1 RISING HEALTH-CONSCIOUSNESS, HECTIC LIFESTYLES OF WORKING POPULATION, AND GROWING INCLINATION TOWARD HEALTHY BEVERAGES TO PROPEL MARKET
  • 8.3.2 ENERGY DRINKS
  • 8.3.3 JUICES
  • 8.3.4 HEALTH DRINKS
• 8.4 ANIMAL NUTRITION
  • 8.4.1 INCREASE IN DEMAND FOR ANIMAL HEALTH AND NUTRITION TO FUEL DEMAND FOR NUTRACEUTICAL INGREDIENTS IN ANIMAL NUTRITION
  • 8.4.2 AMINO ACID IN ANIMAL NUTRITION
• 8.5 DIETARY SUPPLEMENTS
  • 8.5.1 CONSUMER AWARENESS AND GROWING INCLINATION TOWARD INITIATIVE-TAKING HEALTH MANAGEMENT TO FOSTER MARKET GROWTH
• 8.6 FOOD FOR SPECIAL MEDICAL PURPOSES (FSMP)
  • 8.6.1 ADVANCEMENTS IN MEDICAL RESEARCH, INCREASING AWARENESS ABOUT CLINICAL NUTRITION, AND CONTINUOUS EMERGENCE OF NEW MEDICAL CONDITIONS TO BOOST MARKET GROWTH

9 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM

• 9.1 INTRODUCTION
• 9.2 DRY
  • 9.2.1 SUPERIOR STABILITY, CONVENIENT HANDLING, AND LONGER SHELF-LIFE TO FUEL DEMAND FOR DRY FORM OF INGREDIENTS
• 9.3 LIQUID
  • 9.3.1 EASE OF CONSUMPTION AND FASTER ABSORPTION RATES TO FOSTER DEMAND FOR LIQUID FORM OF INGREDIENTS

10 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTION

• 10.1 INTRODUCTION
• 10.2 ADDITIONAL SUPPLEMENTS
  • 10.2.1 NEED TO ADDRESS SPECIFIC DEFICIENCIES, MANAGE HEALTH CONDITIONS, AND ENHANCE PHYSICAL APPEARANCE TO BOOST MARKET GROWTH
  • 10.2.2 NUTRITION
  • 10.2.3 WEIGHT MANAGEMENT
  • 10.2.4 SKIN HEALTH
• 10.3 MEDICINAL SUPPLEMENTS
  • 10.3.1 INCREASING CONSUMER AWARENESS ABOUT PREVENTIVE HEALTHCARE AND RISING INCIDENCES OF LIFESTYLE-RELATED DISEASES TO DRIVE MARKET
  • 10.3.2 GUT HEALTH
  • 10.3.3 HEART HEALTH
  • 10.3.4 BONE HEALTH
  • 10.3.5 IMMUNITY
  • 10.3.6 EYE HEALTH
  • 10.3.7 OTHER MEDICAL SUPPLEMENTS
• 10.4 SPORTS NUTRITION
  • 10.4.1 INCREASED NUTRIENT REQUIREMENTS DUE TO DEMANDING PHYSICAL ACTIVITIES TO DRIVE DEMAND

11 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 US
    • 11.2.1.1 Increased consumer demand for fortified food & beverages and rising healthcare costs to drive market
  • 11.2.2 CANADA
    • 11.2.2.1 High prevalence of inadequate vitamin D and calcium levels, rising food industry, and growing consumer health awareness to propel market
  • 11.2.3 MEXICO
    • 11.2.3.1 Rise in per capita expenditure on nutritious and healthy foods to fuel demand for nutraceutical ingredients
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 Growing dietary supplement industry and focus on functional foods to address health concerns to boost market growth
  • 11.3.2 UK
    • 11.3.2.1 Rising awareness regarding healthy diet and increasing demand for dietary ingredients to drive market
  • 11.3.3 FRANCE
    • 11.3.3.1 Increased health awareness and strategic government initiatives to foster market
  • 11.3.4 ITALY
    • 11.3.4.1 High consumption of food supplements and functional foods, widespread acceptance of probiotic products, and rising awareness of associated health benefits to accelerate market growth
  • 11.3.5 SPAIN
    • 11.3.5.1 Increased pork production to drive market growth
  • 11.3.6 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 CHINA
    • 11.4.1.1 Growing 'punk nutrition' trend coupled with changing lifestyles to progress market growth
  • 11.4.2 INDIA
    • 11.4.2.1 Emphasis on preventive healthcare due to rising hospitalization costs to foster market growth
  • 11.4.3 JAPAN
    • 11.4.3.1 Weather conditions being suitable for microbial growth and focus on fortified foods to boost market growth
  • 11.4.4 AUSTRALIA & NEW ZEALAND
    • 11.4.4.1 Changing lifestyles, increased purchasing power, and rising spending on nutritional foods to accelerate market growth
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 SOUTH AMERICA
  • 11.5.1 BRAZIL
    • 11.5.1.1 Improved health consciousness, growing urbanization, health consciousness, and escalating obesity rates to propel market
  • 11.5.2 ARGENTINA
    • 11.5.2.1 Prevalence of malnutrition and need for nutritious diet to drive market growth
  • 11.5.3 REST OF SOUTH AMERICA
• 11.6 REST OF THE WORLD (ROW)
  • 11.6.1 MIDDLE EAST
    • 11.6.1.1 Increased demand for healthy food amid rising health concerns to foster market growth
  • 11.6.2 AFRICA
    • 11.6.2.1 Government initiatives for fortification of food with essential vitamins and minerals to boost market growth

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 12.3 REVENUE ANALYSIS
• 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.4.1 MARKET RANKING ANALYSIS
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Regional footprint
    • 12.5.5.3 Type footprint
    • 12.5.5.4 Application footprint
    • 12.5.5.5 Form footprint
• 12.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
    • 12.6.5.1 Key start-ups/SMEs
    • 12.6.5.2 Competitive benchmarking of key start-ups/SMEs
• 12.7 COMPANY VALUATION AND FINANCIAL METRICS
• 12.8 BRAND/PRODUCT COMPARISON
• 12.9 COMPETITIVE SCENARIO AND TRENDS
  • 12.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS
  • 12.9.4 OTHER DEALS/DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 CARGILL, INCORPORATED
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Solutions/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
      • 13.1.1.3.2 Other deals/developments
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices made
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 ADM
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Solutions/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
      • 13.1.2.3.2 Deals
      • 13.1.2.3.3 Other deals/developments
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices made
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 INTERNATIONAL FLAVORS & FRAGRANCES INC.
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Solutions/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches
      • 13.1.3.3.2 Deals
      • 13.1.3.3.3 Other deals/developments
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices made
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 BASF SE
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Solutions/Services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches and enhancements
      • 13.1.4.3.2 Deals
      • 13.1.4.3.3 Other deals/developments
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices made
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 ARLA FOODS AMBA
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Solutions/Services offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product launches
      • 13.1.5.3.2 Deals
      • 13.1.5.3.3 Other deals/developments
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices made
      • 13.1.5.4.3 Weaknesses and competitive threats
  • 13.1.6 DSM-FIRMENICH
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Solutions/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches
      • 13.1.6.3.2 Deals
    • 13.1.6.4 MnM view
  • 13.1.7 INGREDION
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Solutions/Services offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches
      • 13.1.7.3.2 Deals
      • 13.1.7.3.3 Other deals/developments
    • 13.1.7.4 MnM view
  • 13.1.8 TATE & LYLE
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Solutions/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches
      • 13.1.8.3.2 Deals
      • 13.1.8.3.3 Other deals/developments
    • 13.1.8.4 MnM view
  • 13.1.9 AJINOMOTO CO., INC.
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Solutions/Services offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Deals
      • 13.1.9.3.2 Other deals/developments
    • 13.1.9.4 MnM view
  • 13.1.10 ASSOCIATED BRITISH FOODS PLC
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Solutions/Services offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Deals
    • 13.1.10.4 MnM view
  • 13.1.11 CHR. HANSEN A/S
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Solutions/Services offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Product launches and enhancements
      • 13.1.11.3.2 Deals
      • 13.1.11.3.3 Other deals/developments
    • 13.1.11.4 MnM view
  • 13.1.12 KYOWA KIRIN CO., LTD
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Solutions/Services offered
    • 13.1.12.3 Recent developments
    • 13.1.12.4 MnM view
  • 13.1.13 GLANBIA PLC
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products/Solutions/Services offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Product launches
      • 13.1.13.3.2 Deals
      • 13.1.13.3.3 Other deals/developments
    • 13.1.13.4 MnM view
  • 13.1.14 FONTERRA CO-OPERATIVE GROUP LIMITED
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products/Solutions/Services offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Deals
    • 13.1.14.4 MnM view
  • 13.1.15 KERRY GROUP PLC
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products/Solutions/Services offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Product launches
      • 13.1.15.3.2 Deals
      • 13.1.15.3.3 Other deals/developments
    • 13.1.15.4 MnM view
• 13.2 OTHER PLAYERS
  • 13.2.1 DIVI'S LABORATORIES LIMITED
    • 13.2.1.1 Business overview
    • 13.2.1.2 Products/Solutions/Services offered
    • 13.2.1.3 Recent developments
      • 13.2.1.3.1 Product launches
    • 13.2.1.4 MnM view
  • 13.2.2 ROQUETTE FRERES
    • 13.2.2.1 Business overview
    • 13.2.2.2 Products/Solutions/Services offered
    • 13.2.2.3 Recent developments
      • 13.2.2.3.1 Product launches and enhancements
      • 13.2.2.3.2 Other deals/developments
    • 13.2.2.4 MnM view
  • 13.2.3 BENEO
    • 13.2.3.1 Business overview
    • 13.2.3.2 Products/Solutions/Services offered
    • 13.2.3.3 Recent developments
      • 13.2.3.3.1 Other deals/developments
    • 13.2.3.4 MnM view
  • 13.2.4 KEMIN INDUSTRIES, INC.
    • 13.2.4.1 Business overview
    • 13.2.4.2 Products/Solutions/Services offered
    • 13.2.4.3 Recent developments
      • 13.2.4.3.1 Product enhancements
      • 13.2.4.3.2 Other deals/developments
    • 13.2.4.4 MnM view
  • 13.2.5 GOLDEN GRAIN GROUP LIMITED
    • 13.2.5.1 Business overview
    • 13.2.5.2 Products/Solutions/Services offered
    • 13.2.5.3 Recent developments
    • 13.2.5.4 MnM view
  • 13.2.6 COSUCRA
  • 13.2.7 PURIS
  • 13.2.8 PROEON
  • 13.2.9 CONAGEN, INC.
  • 13.2.10 CHICKP

14 ADJACENT & RELATED MARKETS

• 14.1 INTRODUCTION
• 14.2 RESEARCH LIMITATIONS
• 14.3 DIETARY SUPPLEMENTS MARKET
  • 14.3.1 MARKET DEFINITION
  • 14.3.2 MARKET OVERVIEW
  • 14.3.3 DIETARY SUPPLEMENTS MARKET, BY TARGET CONSUMER
  • 14.3.4 DIETARY SUPPLEMENTS MARKET, BY REGION
• 14.4 HEALTH INGREDIENTS MARKET
  • 14.4.1 MARKET DEFINITION
  • 14.4.2 MARKET OVERVIEW
  • 14.4.3 HEALTH INGREDIENTS MARKET, BY SOURCE
  • 14.4.4 HEALTH INGREDIENTS MARKET, BY REGION

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS

관련자료